Business Description
Dicot Pharma AB
ISIN : SE0011178458
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.94 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 45.7 | |||||
3-Year EPS without NRI Growth Rate | 41.7 | |||||
3-Year FCF Growth Rate | 43.9 | |||||
3-Year Book Growth Rate | -42.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 53.85 | |||||
9-Day RSI | 50.97 | |||||
14-Day RSI | 51 | |||||
6-1 Month Momentum % | -23.67 | |||||
12-1 Month Momentum % | 7.13 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 16.76 | |||||
Quick Ratio | 15.92 | |||||
Cash Ratio | 15.52 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -128.3 | |||||
Shareholder Yield % | -36.23 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -97.67 | |||||
ROA % | -84.65 | |||||
ROIC % | -685.34 | |||||
ROC (Joel Greenblatt) % | -11087.56 | |||||
ROCE % | -98.22 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.95 | |||||
Price-to-Tangible-Book | 3.11 | |||||
EV-to-EBIT | -4.86 | |||||
EV-to-EBITDA | -4.86 | |||||
EV-to-FCF | -4.69 | |||||
Price-to-Net-Current-Asset-Value | 3.11 | |||||
Price-to-Net-Cash | 3.11 | |||||
Earnings Yield (Greenblatt) % | -20.58 | |||||
FCF Yield % | -14.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Dicot Pharma AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | |||
EPS (TTM) (kr) | -0.054 | ||
Beta | 0 | ||
Volatility % | 106.08 | ||
14-Day RSI | 51 | ||
14-Day ATR (kr) | 0.012429 | ||
20-Day SMA (kr) | 0.21755 | ||
12-1 Month Momentum % | 7.13 | ||
52-Week Range (kr) | 0.121354 - 0.423635 | ||
Shares Outstanding (Mil) | 1,778.78 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Dicot Pharma AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Dicot Pharma AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Dicot Pharma AB Frequently Asked Questions
What is Dicot Pharma AB(OSTO:DICOT)'s stock price today?
When is next earnings date of Dicot Pharma AB(OSTO:DICOT)?
Does Dicot Pharma AB(OSTO:DICOT) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |